RT Journal Article
T1 Effectiveness of core stability exercises and recovery myofascial release massage on fatigue in breast cancer survivors: a randomized controlled clinical trial.
A1 Cantarero-Villanueva, Irene
A1 Fernández-Lao, Carolina
A1 Moral-Avila, Rosario, del
A1 Fernández-de-Las-Peñas, César
A1 Feriche-Fernández-Castanys, María Belén
A1 Arroyo-Morales, Manuel
K1 Neoplasias de la Mama
K1 Masaje
K1 Fatiga
K1 Femenino
K1 Sobrevivientes
K1 Ensayos Clínicos Controlados Aleatorios como Asunto
K1 Terapia por Ejercicio
AB The purpose of the present paper was to evaluate the effects of an 8-week multimodal program focused on core stability exercises and recovery massage with DVD support for a 6-month period in physical and psychological outcomes in breast cancer survivors. A randomized controlled clinical trial was performed. Seventy-eight (n = 78) breast cancer survivors were assigned to experimental (core stability exercises plus massage-myofascial release) and control (usual health care) groups. The intervention period was 8 weeks. Mood state, fatigue, trunk curl endurance, and leg strength were determined at baseline, after the last treatment session, and at 6 months of followup. Immediately after treatment and at 6 months, fatigue, mood state, trunk curl endurance, and leg strength exhibited greater improvement within the experimental group compared to placebo group. This paper showed that a multimodal program focused on core stability exercises and massage reduced fatigue, tension, depression, and improved vigor and muscle strength after intervention and 6 months after discharge.
PB Hindawi Publishing Corporation
SN 1741-427X
YR 2012
FD 2012-06-06
LK http://hdl.handle.net/10668/778
UL http://hdl.handle.net/10668/778
LA en
NO Cantarero-Villanueva I, Fernández-Lao C, Moral-Avila R del, Fernández-de-Las-Peñas C, Feriche-Fernández-Castanys MB, Arroyo-Morales M. Effectiveness of core stability exercises and recovery myofascial release massage on fatigue in breast cancer survivors: a randomized controlled clinical trial. Evid Based Complement Alternat Med; 2012:620619
NO Journal Article;
DS RISalud
RD Apr 6, 2025